Products
Online Inquiry

Please note that we are not a pharmacy or clinic, so we are unable to see patients and do not offer diagnostic and treatment services for individuals.

Vitamin B12 test kit

Acetohexamide

Cat. No.: OB0225WX-2635
Appearance: Solid
Purity: ≥99%
Identity: Confirmed by NMR, and HPLC.
Size:
Acetohexamide
Add to basket

Product Overview

Description: Acetohexamide is a first-generation sulfonylurea that lowers blood glucose by stimulating insulin secretion from pancreatic beta cells and enhancing peripheral insulin efficiency.
Synonym: 968-81-0; Dymelor; Acetohexamid; Dimelor; Gamadiabet; Hypoglicil; Metaglucina; Tsiklamid; Minoral; Ordimel; Acetohexamida; Acetohexamidum; 1-(4-acetylphenyl)sulfonyl-3-cyclohexylurea; N-(p-Acetylphenylsulfonyl)-N'-cyclohexylurea; 1-((p-Acetylphenyl)sulfonyl)-3-cyclohexylurea; 1-(p-Acetylbenzenesulfonyl)-3-cyclohexylurea; HSDB 3280; U-14812; 4-Acetyl-N-((cyclohexylamino)carbonyl)benzenesulfonamide; 4-Acetyl-N-[(cyclohexylamino)carbonyl]benzenesulfonamide; N-(p-Acetylbenzenesulfonyl)-N'-cyclohexylurea; Benzenesulfonamide, 4-acetyl-N-[(cyclohexylamino)carbonyl]-; DTXCID707; Benzenesulfonamide, 4-acetyl-N-((cyclohexylamino)carbonyl)-; 3-(4-acetylbenzenesulfonyl)-1-cyclohexylurea; Acetohexamide-d11; 4-acetyl-N-(cyclohexylcarbamoyl)benzenesulfonamide; Urea, 1-((p-acetylphenyl)sulfonyl)-3-cyclohexyl-
CAS No.: 968-81-0
Compound CID: 1989
Formula: C15H20N2O4S
Formula Weight: 324.4

Specification

Stability: 3 years in powder form.
Storage: Storage at -20°C.
Applications: Acetohexamide is employed in diabetes research as a first-generation sulfonylurea to study the stimulation of pancreatic insulin secretion and the regulation of glucose metabolism in hyperglycemic models.

Library Information

Target: Others
Pathways: Others
Plate Number: L6700-07
Empty Location: a1-h1; a12-h12
Container: 96-well plate
Formulation: 10mM DMSO
DMSO Max Solubility: 11 mg/mL; 33.91 mM
ALogP: 2.119
HBA_Count: 4
HBD_Count: 2
Rotatable Bond: 4
Inquiry
0
Inquiry Basket

Copyright © Protheragen. All rights reserves.